Article
Identification of TRIML2, a novel p53 target, that enhances p53 SUMOylation and regulates the transactivation of proapoptotic genes.
Molecular cancer research : MCR - 1 Feb 2015
Kung Che-Pei, Khaku Sakina, Jennis Matthew, Zhou Yan, Murphy Maureen E
Abstract excerpt
UNLABELLED: The tumor-suppressor protein p53, encoded by TP53, inhibits tumorigenesis by inducing cell-cycle arrest, senescence, and apoptosis. Several genetic polymorphisms exist in TP53, including a proline to arginine variant at amino acid 72 (P72 and R72, respectively); this polymorphism alters p53 function. In general, the P72 variant shows increased ability to induce cell-cycle arrest, whereas the R72...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
